Skip to main content
Signal8

enVVeno Medical Corp (NVNO)

enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

enVVeno Medical Corporation logo

enVVeno Medical Corporation

NASDAQ:NVNOHealthcare
-2.94%$5.77
CLOSED
AH$5.77+0.00%vs close
Mkt Cap$4.01M
EV-$23.5M
Float691K
O/S695K
VOL11K sh
$ Vol$65K
RVOL0.34×
Inst Own12.6%
SI3.5%
Net Cash/Sh+$39.60
Dilution
enVVeno Medical Corporation logoNASDAQ:NVNOClosed$5.77-2.94%
Financials Summary
Revenue$0
Net Income-$19.47M
Total Assets$29.56M
Free Cash Flow-$15.57M
Debt & Equity
Debt 3%
Equity 97%
Total Debt$700K
Total Equity$27.13M
Shares Outstanding
Short Interest

No short interest data available.

Split History2 splits · 2 reverse
2-year cumulative
1:35

Nasdaq bars a compliance period at 1:250

  1. 1:35Reverse split
    Jan 20, 202635 shares → 1
  2. 1:25Reverse split
    Nov 30, 202025 shares → 1
Balance Sheet Details
Assets$29.56M
Liabilities$2.43M
Accounts Receivable$0
Accounts Payable$358K
Inventory$0
PP&E (Net)$705K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$0$0$0$0$0$0$31K$187K$422K$786K$0$237K
YoY Growth-------83.3%-55.8%-46.3%---
Cost of Revenue$0$528K$546K$525K$453K$384K$0$0$559K$961K$125K$266K
Gross Profit$0-$528K-$546K-$525K-$453K-$384K$31K$187K-$137K-$176K-$125K-$30K
Gross Margin------100.0%100.0%-32.4%-22.3%--12.7%
Research and Development$9.98M$12.25M$13.58M$9.91M$5.73M$4.25M$2.21M$1.24M$650K$0$0$0
Selling, General, and Administrative$10.92M$11.05M$11.11M$14.49M$10.71M$4.5M$4.51M$6.35M$5.32M$4.48M$1.16M$923K
Other$0$0$0$0$0$0$985K$453K$0$0$0$0
Total Operating Expenses$20.9M$23.3M$24.69M$24.41M$16.44M$8.75M$7.71M$8.04M$5.97M$4.48M$1.16M$923K
Operating Income (EBIT)-$20.9M-$23.83M-$25.24M-$24.93M-$16.89M-$9.14M-$7.68M-$7.85M-$6.1M-$4.66M-$1.29M-$953K
Operating Margin-------24566.5%-4210.5%-1445.9%-592.8%--402.8%
Interest Expense$0$0$0$0$0-$4K$933$6.86M$1.92M$58K$89K$65K
Interest Income$692K$389K$180K$161K$19K$0$51K$0$0$0$0$0
Other Income (Expense)$1.43M$2.01M$1.72M$263K$365K-$360$50K-$5.19M-$1.69M-$929K-$88K-$65K
Income Before Tax (EBT)-$19.47M-$21.82M-$23.52M-$24.67M-$16.53M-$9.14M-$7.63M-$13.04M-$7.79M-$5.59M-$1.38M-$1.02M
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
Net Income-$19.47M-$21.82M-$23.52M-$24.67M-$16.53M-$9.14M-$7.63M-$13.04M-$7.79M-$5.89M-$1.6M-$1.4M
Net Income Margin-------24406.7%-6991.5%-1845.8%-749.0%--591.1%
Supplementary Data
EPS-33.06-1555.75-2339.75-2695.00-2327.50-9236.50-14822.50-53495.75-26068.00-10412.50-4483.50-5194.00
Diluted EPS-33.06-1555.75-2339.75-2695.00-2327.50-9236.50-14822.50-53495.75-26068.00-10412.50-4483.50-5194.00
Weighted Average OS589,00013,99310,0429,1677,0861,054515306316358358196
EBITDA-$18.98M-$21.29M-$22.97M-$24.14M-$16.07M-$8.75M-$7.23M-$6.05M-$5.73M-$5.38M-$1.16M-$819K
EBITDA Margin-------23134.1%-3242.2%-1358.1%-684.5%--346.1%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Assets
Current Assets
Cash and Cash Equivalents$3.06M$1.75M$3.62M$4.55M$54.73M$9.33M$1.31M$2.74M$78K$57K$1.59M$58K
Short-Term Investments$25.15M$41.4M$42.79M$34.49M$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$28.21M$43.15M$46.41M$39.04M$54.73M$9.33M$1.31M$2.74M$78K$57K$1.59M$58K
Accounts Receivable$0$0$0$0$0$0$0$32K$35K$200K$0$0
Inventory$0$0$0$0$0$0$0$0$0$91K$0$0
Other Current Assets$614K$581K$511K$392K$312K$234K$117K$64K$58K$0$184K$392K
Total Current Assets$28.83M$43.73M$46.92M$39.44M$55.04M$9.57M$1.42M$2.84M$170K$393K$1.78M$485K
Long-Term Assets
Property, Plant & Equipment Net$705K$1.19M$1.68M$2.19M$2.6M$939K$1.17M$26K$24K$29K$65K$110K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$666K$1.11M$1.23M$899K$977K
Long-Term Investments$0$0$0$0$0$0$810K$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$31K$31K$31K$31K$54K$30K$30K$30K$911K$128K$126K$26K
Total Long-Term Assets$736K$1.22M$1.71M$2.23M$2.66M$969K$2.01M$722K$2.04M$1.39M$1.09M$1.11M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$29.56M$44.95M$48.63M$41.66M$57.7M$10.54M$3.43M$3.56M$2.21M$1.78M$2.87M$1.6M
Liabilities
Current Liabilities
Accounts Payable$358K$1.01M$427K$648K$560K$1.39M$1.22M$1.08M$1.45M$542K$618K$702K
Short-Term Debt$0$364K$0$0$0$313K$0$0$2.62M$633K$1.83M$1.07M
Current Income Tax Payable$0$0$0$0$0$26K$30K$27K$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$33K$33K$33K$103K$0$0$33K
Other Current Liabilities$929K$121K$606K$450K$585K$499K$152K$311K$3.64M$857K$2.16M$1.66M
Total Current Liabilities$2.12M$2.1M$1.37M$1.53M$1.58M$3.19M$1.88M$1.52M$8.17M$2.07M$4.66M$3.61M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$33K$103K$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$3.08M$551K$74K$0
Total Long-Term Liabilities$310K$700K$1.06M$1.4M$1.71M$254K$568K$33K$3.18M$551K$74K$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$2.43M$2.79M$2.44M$2.93M$3.29M$3.44M$2.44M$1.52M$8.17M$2.07M$4.66M$3.61M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$5.17M$3.94M$1.8M$0
Common Stock$0$0$0$0$95$25$179$117$61$122$120$120
Retained Earnings-$171.33M-$151.85M-$130.04M-$106.52M-$81.85M-$65.32M-$56.19M-$48.56M-$35.52M-$27.73M-$24.34M-$22.74M
Comprehensive Income & Other$0$0$0$0$0$0$0$0-$5.17M-$3.94M$0$0
Other Stockholders' Equity$198.46M$194.01M$176.24M$145.25M$136.26M$72.42M$57.18M$50.6M$24.39M$23.51M$22.56M$20.73M
Total Equity$27.13M$42.16M$46.2M$38.73M$54.4M$7.1M$990K$2.04M-$11.13M-$4.22M-$1.78M-$2.01M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$29.56M$44.95M$48.63M$41.66M$57.7M$10.54M$3.43M$3.56M-$2.96M-$2.15M$2.87M$1.6M
Supplementary Data
Total Debt$700K$1.06M$1.4M$1.72M$2.01M$881K$857K$0$2.62M$633K$1.83M$1.07M
Net Debt-$2.37M-$690K-$2.22M-$2.84M-$52.72M-$8.45M-$451K-$2.74M$2.54M$576K$246K$1.01M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Operating Activities
Net Income-$19.47M-$21.82M-$23.52M-$24.67M-$16.53M-$9.14M-$7.63M-$13.04M-$7.79M-$3.39M-$1.6M-$1K
Depreciation & Amortization$489K$528K$546K$525K$453K$384K$397K$133K$139K$151K$125K$134K
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$3.42M$4.14M$5.2M$8.99M$6M$881K$942K$1.92M$878K$1.51M$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$32K$3K-$12K-$24K$25K-$6
  Inventory$0$0$0$0$0$0$0$0$91K-$213K$172K-$152
  Accounts Payable$0$0-$221K$88K-$833K$169K$144K-$294K$545K-$76K-$84K$0
  Other Working Capital-$396K$290K-$395K-$508K-$313K$497K-$109K-$287K$468K$250K-$654K$159
Total Working Capital Change-$396K$290K-$616K-$420K-$1.15M$666K$67K-$578K$1.09M-$63K-$541K$0
Other Non-Cash Items$391K$22K-$468K-$49K-$626K-$473K$324K$5.21M$1.48M-$1.63M-$177-$133K
Net Cash from Operating-$15.57M-$16.84M-$18.86M-$15.62M-$11.85M-$7.68M-$5.9M-$6.36M-$4.2M-$3.42M-$2.02M$122
Investing Activities
Capital Expenditures-$5K-$37K-$33K-$115K-$368K-$180K-$364K-$12K-$11K-$3K-$3K-$31
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$46.02M-$55.57M-$56.52M-$48.13M$0$0$0$0$0$0$0$0
Sales of Investments$61.88M$56.94M$48.69M$13.69M$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0$0$176K-$369K-$75K$0
Net Cash from Investing$15.86M$1.33M-$7.87M-$34.55M-$368K-$180K-$364K-$12K$165K-$373K-$78K-$31
Financing Activities
Debt Repaid------$313K--$723K-$275K---
Common Stock Issuance$1.02M$13.64M$25.79M$0$57.61M$10.42M$5.64M$7.66M$0$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$0$2.99M$0-$707K-$210K-$589K$746K$60K
Net Cash from Financing$1.02M$13.64M$25.79M$0$57.61M$15.07M$5.64M$9.03M$4.06M$2.26M$3.62M-$60
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$1.31M-$1.87M-$935K-$50.17M$45.39M$7.22M-$623K$2.66M$21K-$1.53M$1.53M$31
Supplementary Data
Operating Cash Flow-$15.57M-$16.84M-$18.86M-$15.62M-$11.85M-$7.68M-$5.9M-$6.36M-$4.2M-$3.42M-$2.02M$122
Capital Expenditure-$5K-$37K-$33K-$115K-$368K-$180K-$364K-$12K-$11K-$374K-$3K-$31
Free Cash Flow-$15.57M-$16.88M-$18.89M-$15.73M-$12.22M-$7.86M-$6.26M-$6.37M-$4.21M-$3.79M-$2.02M$91
Cash at Beginning$1.75M$3.62M$4.55M$54.73M$9.34M$2.12M$2.74M$78K$57K$1.59M$58K$27
Cash at End$3.06M$1.75M$3.62M$4.55M$54.73M$9.33M$2.12M$2.74M$78K$57K$1.59M$58